Volufiline for hollow under-eyes: what the science actually shows

What's this video probably claiming?

Based on the caption and hashtag context, @illaalvarez is almost certainly positioning volufiline as a targeted fix for the hollow, sunken under-eye look, sometimes called the tear trough depression. The SKIN1004 Matrixyl 10 Boosting Shot Ampoule is the vehicle here, and the framing is that volufiline specifically drives volume back into that area. The "THAT ingredient" construction is classic TikTok superlative language, implying this ingredient does something other skincare actives don't. Given the peptides category context, the implicit comparison is likely to more invasive volume-restoration options like filler or even injectable peptides. The centella hashtag is a bit of a red herring since the product name leans harder into Matrixyl (palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7), and volufiline is the separate lipid-boosting compound doing the heavy lifting in this particular claim.

What does the science actually show?

Volufiline is a trademarked compound from Sederma consisting of sarsasapogenin (a steroidal saponin from Anemarrhena asphodeloides root) suspended in hydrogenated polyisobutene. The mechanistic claim is that it stimulates adipogenesis, specifically encouraging lipid accumulation in adipocyte-like cells, which would theoretically increase soft tissue volume under the skin. The primary supporting data is an in vitro study published by Sederma itself showing increased lipid droplet accumulation in pre-adipocyte cell cultures. A small manufacturer-sponsored clinical study reportedly showed a 6.37% increase in lip volume after eight weeks of topical application at 5% concentration. That's a real number, but it comes from a single-site, industry-funded trial. Independent peer-reviewed replication in reputable journals like the Journal of Cosmetic Dermatology or JEADV is essentially absent. The under-eye claim specifically has no dedicated clinical trial data that is publicly available or independently verified.

Where does the social media noise diverge from clinical reality?

The gap here is significant. TikTok's volufiline content treats the ingredient as roughly equivalent to a topical filler, which is not what the evidence supports. First, the concentration problem: most serums, including the SKIN1004 product, do not disclose the exact percentage of volufiline used. The only studied concentration with any measurable effect is 5%, and without that disclosure, efficacy comparisons are meaningless. Second, penetration is a real issue. The periorbital skin is thin, but adipose tissue sits below the dermis, and getting a large sarsasapogenin molecule to meaningfully reach and stimulate preadipocytes through intact skin barrier is not a solved problem. Third, creators are applying tear trough depression logic to topical skincare, when that hollow is primarily caused by fat pad displacement and bone remodeling with age, not simple fat loss that a topical adipogenic compound could reverse. The mechanism doesn't map cleanly onto the actual anatomy of under-eye hollowing.

What should you actually know?

Volufiline is not a scam ingredient, but it is a significantly overhyped one in this specific application. If you have mild surface-level hollowing from dehydration or thin skin, a well-formulated eye product could plausibly offer some cosmetic improvement through hydration and skin-plumping effects alone, regardless of the volufiline. The Matrixyl peptide complex (palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7) in this product actually has stronger independent evidence behind it for collagen stimulation, with Lintner and Mas-Chamberlin (2002, International Journal of Cosmetic Science) and Robinson et al. (2005, International Journal of Cosmetic Science) supporting its collagen-stimulating activity. If your hollow under-eyes are structural, meaning they involve fat pad descent or significant bone loss, no topical ingredient is going to move that needle in any clinically meaningful way. Managing expectations here is the job, and this video almost certainly isn't doing that.